“…This permitted adding three further examples, which were randomly selected based on disorder being reported from a search in the CSD. The datasets used were: I, methyl (4-bromophenyl)(3-tert-butyl-1H-indol-1-research papers yl)acetate, refcode CAWWIJ (Arredondo et al, 2017); II, erlotinib, refcode DULKAX (Sridhar et al, 2010); III, 4-(4methoxyphenyl)piperazin-1-ium (MeOPP) 4-fluorobenzoate monohydrate, refcode FOVPOY (Kiran Kumar et al, 2019); IV, DL-arginine monohydrate, refcode FUGXIO01 with intensity data (lattice parameters) from a subsequent chargedensity study (Kingsford-Adaboh et al, 2000; V, 1-(2bromo-3-{[tert-butyl(dimethyl)silyl]oxy}phenyl)-2,2-dimethylbut-3-en-1-yl 4-nitro-benzoate, refcode IRUMAL (Ghosh & Kassekert, 2016); VI, telaprevir, refcode LERJID (Gelbrich et al, 2013); VII, irbesartan bromide sesquihydrate, refcode NIQVIT (Wang et al, 2007); VIII, duloxetine hydrochloride, refcode MUCDUK (Bhadbhade et al, 2009); IX, darifenacin hydrobromide, refcode SOYMID (Selvanayagam et al, 2009); and X, propionamide, refcode ZZZKAY03 at 100 K (Fabbiani et al, 2014). For propionamide there is an additional roomtemperature structure relevant here, with refcode ZZZKAY05 (Fabbiani et al, 2014).…”